Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Preparing word cloud

×

Search

Type in a keyword to search

Filter by last modified time
See new records

Current Facets and Filters

  • Category : Ascending

Facets

Sort alphabetically | Sort by count

Recent searches

121,559 Results - per page

IDNameOrganismDiseaseCommentsProper CitationReferenceCategorySexSynonymsVendorCat NumCross ReferencesHierarchyOriginate from Same Individual
CVCL_HA67IOMM-Lee-LucNeoHomo sapiensMeningiomaSequence variation: BRAF p.Val600Glu (c.1799T>A) (from parent cell line). Transfected with: UniProtKB; P08659; Firefly luciferase. Transfected with: UniProtKB; P00552; Transposon Tn5 neo. DT Created: 01-12-16; Last updated: 05-07-19; Version: 4RRID:CVCL_HA67PMID:18240927Cancer cell line DT Created: 01-12-16; Last updated: 05-07-19; Version: 4DT Created: 01-12-16; Last updated: 05-07-19; Version: 4DT Created: 01-12-16, Last updated: 05-07-19, Version: 4Wikidata; Q54897855 DT Created: 01-12-16; Last updated: 05-07-19; Version: 4DT Created: 01-12-16; Last updated: 05-07-19; Version: 4DT Created: 01-12-16; Last updated: 05-07-19; Version: 4
CVCL_HE14Panc 04.03 MAP2K4(-/-)Homo sapiensPancreatic ductal adenocarcinomaKnockout cell: Method=Homologous recombination; HGNC; 6844; MAP2K4. Sequence variation: ATG7-RAF1 gene fusion (from parent cell line). Sequence variation: Heterozygous for KRAS p.Gly12Asp (c.35G>A) (from parent cell line). Sequence variation: Homozygous for TP53 p.Gly245Ser (c.733G>A) (from parent cell line). DT Created: 01-12-16; Last updated: 05-07-19; Version: 4RRID:CVCL_HE14PMID:16740690Cancer cell line DT Created: 01-12-16; Last updated: 05-07-19; Version: 4DT Created: 01-12-16; Last updated: 05-07-19; Version: 4MAP2K4 (-/-) Panc 04.03, MKK4-/- cells DT Created: 01-12-16, Last updated: 05-07-19, Version: 4Wikidata; Q54937519 DT Created: 01-12-16; Last updated: 05-07-19; Version: 4DT Created: 01-12-16; Last updated: 05-07-19; Version: 4DT Created: 01-12-16; Last updated: 05-07-19; Version: 4
CVCL_HX11XG-10Homo sapiensPlasma cell myelomaCharacteristics: IL6 dependent. HLA typing: A*01,24; B*14,51; C*08,14 (Direct_author_submission). Sequence variation: Has no TP53 mutation (PubMed=21173094). Omics: Deep exome analysis. Omics: Transcriptome analysis. Miscellaneous: HLA typing from personal communication of Pellat-Deceunynck C. Derived from sampling site: Ascites. DT Created: 01-12-16; Last updated: 05-07-19; Version: 4RRID:CVCL_HX11References (4)Cancer cell line DT Created: 01-12-16; Last updated: 05-07-19; Version: 4DT Created: 01-12-16; Last updated: 05-07-19; Version: 4XG10 DT Created: 01-12-16, Last updated: 05-07-19, Version: 4ArrayExpress; E-TABM-1088 IARC_TP53; 28491 Wikidata; Q54994695 DT Created: 01-12-16; Last updated: 05-07-19; Version: 4DT Created: 01-12-16; Last updated: 05-07-19; Version: 4DT Created: 01-12-16; Last updated: 05-07-19; Version: 4
CVCL_HX13XG-12Homo sapiensPlasma cell myelomaCharacteristics: Produces Ig lambda. Characteristics: IL6 dependent. Sequence variation: NRAS p.Gln61Leu (c.182A>T) (PubMed=21173094). Sequence variation: Has no TP53 mutation (PubMed=21173094). Omics: Transcriptome analysis. Derived from sampling site: Peripheral blood. DT Created: 01-12-16; Last updated: 05-07-19; Version: 4RRID:CVCL_HX13PMID:21173094Cancer cell line DT Created: 01-12-16; Last updated: 05-07-19; Version: 4DT Created: 01-12-16; Last updated: 05-07-19; Version: 4XG12 DT Created: 01-12-16, Last updated: 05-07-19, Version: 4ArrayExpress; E-TABM-1088 IARC_TP53; 28493 Wikidata; Q54994697 DT Created: 01-12-16; Last updated: 05-07-19; Version: 4DT Created: 01-12-16; Last updated: 05-07-19; Version: 4DT Created: 01-12-16; Last updated: 05-07-19; Version: 4
CVCL_HX17XG-19Homo sapiensPlasma cell myelomaCharacteristics: Produces IgA lambda. Characteristics: IL6 dependent. Sequence variation: Has no TP53 mutation (PubMed=21173094). Omics: Transcriptome analysis. Derived from sampling site: Peripheral blood. DT Created: 01-12-16; Last updated: 05-07-19; Version: 4RRID:CVCL_HX17PMID:21173094Cancer cell line DT Created: 01-12-16; Last updated: 05-07-19; Version: 4DT Created: 01-12-16; Last updated: 05-07-19; Version: 4XG19 DT Created: 01-12-16, Last updated: 05-07-19, Version: 4ArrayExpress; E-TABM-1088 IARC_TP53; 28494 Wikidata; Q54994703 DT Created: 01-12-16; Last updated: 05-07-19; Version: 4DT Created: 01-12-16; Last updated: 05-07-19; Version: 4DT Created: 01-12-16; Last updated: 05-07-19; Version: 4
CVCL_HX18XG-20Homo sapiensPlasma cell myelomaCharacteristics: Produces Ig lambda. Characteristics: IL6 dependent. Omics: Transcriptome analysis. Derived from sampling site: Peripheral blood. DT Created: 01-12-16; Last updated: 05-07-19; Version: 4RRID:CVCL_HX18PMID:21173094Cancer cell line DT Created: 01-12-16; Last updated: 05-07-19; Version: 4DT Created: 01-12-16; Last updated: 05-07-19; Version: 4XG20 DT Created: 01-12-16, Last updated: 05-07-19, Version: 4ArrayExpress; E-TABM-1088 Wikidata; Q54994705 DT Created: 01-12-16; Last updated: 05-07-19; Version: 4DT Created: 01-12-16; Last updated: 05-07-19; Version: 4DT Created: 01-12-16; Last updated: 05-07-19; Version: 4
CVCL_HX19XG-21Homo sapiensPlasma cell myelomaCharacteristics: Produces Ig lambda. Characteristics: IL6 dependent. Sequence variation: Has no TP53 mutation (PubMed=21173094). Omics: Transcriptome analysis. Derived from sampling site: Pleural effusion. DT Created: 01-12-16; Last updated: 05-07-19; Version: 4RRID:CVCL_HX19PMID:21173094Cancer cell line DT Created: 01-12-16; Last updated: 05-07-19; Version: 4DT Created: 01-12-16; Last updated: 05-07-19; Version: 4XG21 DT Created: 01-12-16, Last updated: 05-07-19, Version: 4ArrayExpress; E-TABM-1088 IARC_TP53; 28507 Wikidata; Q54994706 DT Created: 01-12-16; Last updated: 05-07-19; Version: 4DT Created: 01-12-16; Last updated: 05-07-19; Version: 4DT Created: 01-12-16; Last updated: 05-07-19; Version: 4
CVCL_HX20XG-24Homo sapiensPlasma cell myelomaCharacteristics: Produces IgA lambda. Characteristics: IL6 dependent. Sequence variation: Has no TP53 mutation (PubMed=21173094). Omics: Transcriptome analysis. Derived from sampling site: Peripheral blood. DT Created: 01-12-16; Last updated: 05-07-19; Version: 4RRID:CVCL_HX20PMID:21173094Cancer cell line DT Created: 01-12-16; Last updated: 05-07-19; Version: 4DT Created: 01-12-16; Last updated: 05-07-19; Version: 4XG24 DT Created: 01-12-16, Last updated: 05-07-19, Version: 4ArrayExpress; E-TABM-1088 IARC_TP53; 28515 Wikidata; Q54994708 DT Created: 01-12-16; Last updated: 05-07-19; Version: 4DT Created: 01-12-16; Last updated: 05-07-19; Version: 4DT Created: 01-12-16; Last updated: 05-07-19; Version: 4
CVCL_HA89GEM-MIA PaCa-2Homo sapiensPancreatic ductal adenocarcinomaSelected for resistance to: ChEBI; CHEBI:175901; Gemcitabine (Gemzar). Sequence variation: Homozygous for CDKN2A deletion (from parent cell line). Sequence variation: Homozygous for KRAS p.Gly12Cys (c.34G>T) (from parent cell line). Sequence variation: Homozygous for TP53 p.Arg248Trp (c.742C>T) (from parent cell line). DT Created: 01-12-16; Last updated: 05-07-19; Version: 5RRID:CVCL_HA89PMID:14508125Cancer cell line DT Created: 01-12-16; Last updated: 05-07-19; Version: 5DT Created: 01-12-16; Last updated: 05-07-19; Version: 5GEM,MIA PaCa-2 DT Created: 01-12-16, Last updated: 05-07-19, Version: 5Wikidata; Q54835559 DT Created: 01-12-16; Last updated: 05-07-19; Version: 5DT Created: 01-12-16; Last updated: 05-07-19; Version: 5DT Created: 01-12-16; Last updated: 05-07-19; Version: 5
CVCL_HE77HepG2T14Homo sapiensHepatoblastomaCharacteristics: This cell line has been transfected with a circular HBV. Sequence variation: NRAS p.Gln61Leu (c.182A>T) (from parent cell line). Sequence variation: TERT c.228C>T (-124C>T); in promoter (from parent cell line). Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV). DT Created: 01-12-16; Last updated: 05-07-19; Version: 5RRID:CVCL_HE77References (2)Cancer cell line DT Created: 01-12-16; Last updated: 05-07-19; Version: 5DT Created: 01-12-16; Last updated: 05-07-19; Version: 5HepG2T-14 DT Created: 01-12-16, Last updated: 05-07-19, Version: 5Wikidata; Q54882864 DT Created: 01-12-16; Last updated: 05-07-19; Version: 5DT Created: 01-12-16; Last updated: 05-07-19; Version: 5DT Created: 01-12-16; Last updated: 05-07-19; Version: 5
CVCL_HE78HepG2T14.1Homo sapiensHepatoblastomaCharacteristics: This cell line has been transfected with a circular HBV. Characteristics: Has lost chromosome Y. Sequence variation: NRAS p.Gln61Leu (c.182A>T) (from parent cell line). Sequence variation: TERT c.228C>T (-124C>T); in promoter (from parent cell line). Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV). DT Created: 01-12-16; Last updated: 05-07-19; Version: 5RRID:CVCL_HE78PMID:9247614Cancer cell line DT Created: 01-12-16; Last updated: 05-07-19; Version: 5DT Created: 01-12-16; Last updated: 05-07-19; Version: 5DT Created: 01-12-16, Last updated: 05-07-19, Version: 5Wikidata; Q54882865 DT Created: 01-12-16; Last updated: 05-07-19; Version: 5DT Created: 01-12-16; Last updated: 05-07-19; Version: 5DT Created: 01-12-16; Last updated: 05-07-19; Version: 5
CVCL_HX06BCNHomo sapiensPlasma cell myelomaCharacteristics: Produces IgG kappa. Characteristics: IL6 dependent. HLA typing: A*11,26; B*13,27; C*02:02,06:02 (Direct_author_submission). Omics: Deep exome analysis. Omics: Transcriptome analysis. Miscellaneous: HLA typing from personal communication of Pellat-Deceunynck C. Derived from sampling site: Peripheral blood. DT Created: 01-12-16; Last updated: 05-07-19; Version: 5RRID:CVCL_HX06References (4)Cancer cell line DT Created: 01-12-16; Last updated: 05-07-19; Version: 5DT Created: 01-12-16; Last updated: 05-07-19; Version: 5DT Created: 01-12-16, Last updated: 05-07-19, Version: 5ArrayExpress; E-TABM-1088 Wikidata; Q54795699 DT Created: 01-12-16; Last updated: 05-07-19; Version: 5DT Created: 01-12-16; Last updated: 05-07-19; Version: 5DT Created: 01-12-16; Last updated: 05-07-19; Version: 5
CVCL_HX07MDNHomo sapiensPlasma cell myelomaCharacteristics: IL6 dependent. HLA typing: A*01,02:09; B*44,51; C*14 (Direct_author_submission). Omics: Deep exome analysis. Omics: Transcriptome analysis. Miscellaneous: HLA typing from personal communication of Pellat-Deceunynck C. Derived from sampling site: Peripheral blood. DT Created: 01-12-16; Last updated: 05-07-19; Version: 5RRID:CVCL_HX07References (4)Cancer cell line DT Created: 01-12-16; Last updated: 05-07-19; Version: 5DT Created: 01-12-16; Last updated: 05-07-19; Version: 5DT Created: 01-12-16, Last updated: 05-07-19, Version: 5ArrayExpress; E-TABM-1088 Wikidata; Q54904815 DT Created: 01-12-16; Last updated: 05-07-19; Version: 5DT Created: 01-12-16; Last updated: 05-07-19; Version: 5DT Created: 01-12-16; Last updated: 05-07-19; Version: 5
CVCL_HX08NAN-2Homo sapiensPlasma cell myelomaCharacteristics: Produces IgG lambda. Characteristics: IL6 dependent. Miscellaneous: Cell line has been lost (from personal communication of Pellat-Deceunynck C.). Derived from sampling site: Peripheral blood. DT Created: 01-12-16; Last updated: 05-07-19; Version: 5RRID:CVCL_HX08PMID:16956823Cancer cell line DT Created: 01-12-16; Last updated: 05-07-19; Version: 5DT Created: 01-12-16; Last updated: 05-07-19; Version: 5NAN2 DT Created: 01-12-16, Last updated: 05-07-19, Version: 5Wikidata; Q54907475 DT Created: 01-12-16; Last updated: 05-07-19; Version: 5DT Created: 01-12-16; Last updated: 05-07-19; Version: 5DT Created: 01-12-16; Last updated: 05-07-19; Version: 5
CVCL_HX09NAN-6Homo sapiensPlasma cell myelomaCharacteristics: Produces IgA kappa. Characteristics: IL6 dependent. HLA typing: A*03,30; B*07,51; C*07,12 (Direct_author_submission). Omics: Deep exome analysis. Omics: Transcriptome analysis. Miscellaneous: Age at sampling and HLA typing from personal communication of Pellat-Deceunynck C. Derived from sampling site: Peripheral blood. DT Created: 01-12-16; Last updated: 05-07-19; Version: 5RRID:CVCL_HX09References (3)Cancer cell line DT Created: 01-12-16; Last updated: 05-07-19; Version: 5DT Created: 01-12-16; Last updated: 05-07-19; Version: 5NAN6 DT Created: 01-12-16, Last updated: 05-07-19, Version: 5ArrayExpress; E-TABM-1088 Wikidata; Q54907479 DT Created: 01-12-16; Last updated: 05-07-19; Version: 5DT Created: 01-12-16; Last updated: 05-07-19; Version: 5DT Created: 01-12-16; Last updated: 05-07-19; Version: 5
CVCL_HX10SBNHomo sapiensPlasma cell myelomaCharacteristics: IL6 dependent. HLA typing: A*02:01,32:01; B*14:02,57; C*06:02,08:02 (Direct_author_submission). Omics: Transcriptome analysis. Miscellaneous: HLA typing from personal communication of Pellat-Deceunynck C. Derived from sampling site: Pleural effusion. DT Created: 01-12-16; Last updated: 05-07-19; Version: 5RRID:CVCL_HX10References (4)Cancer cell line DT Created: 01-12-16; Last updated: 05-07-19; Version: 5DT Created: 01-12-16; Last updated: 05-07-19; Version: 5SBN-1 DT Created: 01-12-16, Last updated: 05-07-19, Version: 5ArrayExpress; E-TABM-1088 Wikidata; Q54952216 DT Created: 01-12-16; Last updated: 05-07-19; Version: 5DT Created: 01-12-16; Last updated: 05-07-19; Version: 5DT Created: 01-12-16; Last updated: 05-07-19; Version: 5
CVCL_HX12XG-11Homo sapiensPlasma cell myelomaCharacteristics: Produces Ig lambda. Characteristics: IL6 dependent. HLA typing: A*02,26; B*18,38; C*07,12 (Direct_author_submission). Sequence variation: TP53 p.Cys135Tyr (c.404G>A) (PubMed=21173094). Omics: Deep exome analysis. Omics: Transcriptome analysis. Miscellaneous: HLA typing from personal communication of Pellat-Deceunynck C. Derived from sampling site: Peripheral blood. DT Created: 01-12-16; Last updated: 05-07-19; Version: 5RRID:CVCL_HX12References (3)Cancer cell line DT Created: 01-12-16; Last updated: 05-07-19; Version: 5DT Created: 01-12-16; Last updated: 05-07-19; Version: 5XG11 DT Created: 01-12-16, Last updated: 05-07-19, Version: 5ArrayExpress; E-TABM-1088 IARC_TP53; 28502 Wikidata; Q54994696 DT Created: 01-12-16; Last updated: 05-07-19; Version: 5DT Created: 01-12-16; Last updated: 05-07-19; Version: 5DT Created: 01-12-16; Last updated: 05-07-19; Version: 5
CVCL_HX14XG-13Homo sapiensPlasma cell myelomaCharacteristics: Produces IgG lambda. Characteristics: IL6 dependent. Sequence variation: TP53 p.Arg248Gln (c.743G>A) (PubMed=21173094). Omics: Transcriptome analysis. Derived from sampling site: Peripheral blood. DT Created: 01-12-16; Last updated: 05-07-19; Version: 5RRID:CVCL_HX14PMID:21173094Cancer cell line DT Created: 01-12-16; Last updated: 05-07-19; Version: 5DT Created: 01-12-16; Last updated: 05-07-19; Version: 5XG13 DT Created: 01-12-16, Last updated: 05-07-19, Version: 5ArrayExpress; E-TABM-1088 IARC_TP53; 28511 Wikidata; Q54994699 DT Created: 01-12-16; Last updated: 05-07-19; Version: 5DT Created: 01-12-16; Last updated: 05-07-19; Version: 5DT Created: 01-12-16; Last updated: 05-07-19; Version: 5
CVCL_HX15XG-14Homo sapiensPlasma cell myelomaCharacteristics: Produces Ig kappa. Characteristics: IL6 dependent. Sequence variation: TP53 p.Gly266Glu (c.797G>A) (PubMed=21173094). Omics: Transcriptome analysis. Derived from sampling site: Peripheral blood. DT Created: 01-12-16; Last updated: 05-07-19; Version: 5RRID:CVCL_HX15PMID:21173094Cancer cell line DT Created: 01-12-16; Last updated: 05-07-19; Version: 5DT Created: 01-12-16; Last updated: 05-07-19; Version: 5XG14 DT Created: 01-12-16, Last updated: 05-07-19, Version: 5ArrayExpress; E-TABM-1088 IARC_TP53; 28512 Wikidata; Q54994700 DT Created: 01-12-16; Last updated: 05-07-19; Version: 5DT Created: 01-12-16; Last updated: 05-07-19; Version: 5DT Created: 01-12-16; Last updated: 05-07-19; Version: 5
CVCL_HX16XG-16Homo sapiensPlasma cell myelomaCharacteristics: Produces Ig kappa. Characteristics: IL6 dependent. HLA typing: A*02,29; B*40,49; C*02,07 (Direct_author_submission). Sequence variation: NRAS p.Gln61His (c.183A>C) (PubMed=21173094). Sequence variation: TP53 p.Tyr220Cys (c.659A>G) (PubMed=21173094). Omics: Deep exome analysis. Omics: Transcriptome analysis. Miscellaneous: HLA typing from personal communication of Pellat-Deceunynck C. Derived from sampling site: Peripheral blood. DT Created: 01-12-16; Last updated: 05-07-19; Version: 5RRID:CVCL_HX16References (2)Cancer cell line DT Created: 01-12-16; Last updated: 05-07-19; Version: 5DT Created: 01-12-16; Last updated: 05-07-19; Version: 5XG16 DT Created: 01-12-16, Last updated: 05-07-19, Version: 5ArrayExpress; E-TABM-1088 IARC_TP53; 28499 Wikidata; Q54994701 DT Created: 01-12-16; Last updated: 05-07-19; Version: 5DT Created: 01-12-16; Last updated: 05-07-19; Version: 5DT Created: 01-12-16; Last updated: 05-07-19; Version: 5
X
  1. RRID Portal Resources

    Welcome to the RRID Resources search. From here you can search through a compilation of resources used by RRID and see how data is organized within our community.

  2. Navigation

    You are currently on the Community Resources tab looking through categories and sources that RRID has compiled. You can navigate through those categories from here or change to a different tab to execute your search through. Each tab gives a different perspective on data.

  3. Logging in and Registering

    If you have an account on RRID then you can log in from here to get additional features in RRID such as Collections, Saved Searches, and managing Resources.

  4. Searching

    Here is the search term that is being executed, you can type in anything you want to search for. Some tips to help searching:

    1. Use quotes around phrases you want to match exactly
    2. You can manually AND and OR terms to change how we search between words
    3. You can add "-" to terms to make sure no results return with that term in them (ex. Cerebellum -CA1)
    4. You can add "+" to terms to require they be in the data
    5. Using autocomplete specifies which branch of our semantics you with to search and can help refine your search
  5. Collections

    If you are logged into RRID you can add data records to your collections to create custom spreadsheets across multiple sources of data.

  6. Facets

    Here are the facets that you can filter the data by.

  7. Further Questions

    If you have any further questions please check out our FAQs Page to ask questions and see our tutorials. Click this button to view this tutorial again.